Literature DB >> 14657382

Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo.

Shu-Ching Shih1, Meihua Ju, Nan Liu, Jan-Rung Mo, Joshua J Ney, Lois E H Smith.   

Abstract

Degeneration of vessels precedes and precipitates the devastating ischemia of many diseases, including retinopathy of prematurity and diabetic retinopathy. Ischemia then leads to proliferative retinopathy and blindness. Understanding the mechanisms of blood vessel degeneration is critical to prevention of these diseases. Vessel loss is associated with oxygen-induced suppression of vascular endothelial growth factor (VEGF) and with pericyte (vascular smooth muscle cell) dropout. The molecular mechanism of pericyte protection of the vasculature is unknown. We show that transforming growth factor beta1 (TGF-beta1)-expressing pericytes are specifically found on vessels resistant to oxygen-induced loss. TGF-beta1 potently induces VEGF receptor 1 (VEGFR-1) expression in endothelial cells and thereby prevents oxygen-induced vessel loss in vivo. Vessel survival is further stimulated with a VEGFR-1-specific ligand, placental growth factor 1. TGF-beta1 induction of VEGFR-1 in endothelial cells explains pericyte protection of vessels and the selective vulnerability of neonatal vessels to oxygen. These results implicate induction and activation of VEGFR-1 as critical targets to prevent vessel loss.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657382      PMCID: PMC307658          DOI: 10.1073/pnas.2136855100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis.

Authors:  U Ozerdem; K A Grako; K Dahlin-Huppe; E Monosov; W B Stallcup
Journal:  Dev Dyn       Date:  2001-10       Impact factor: 3.780

2.  TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells.

Authors:  D C Darland; P A D'Amore
Journal:  Angiogenesis       Date:  2001       Impact factor: 9.596

3.  An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes.

Authors:  A Antonelli-Orlidge; K B Saunders; S R Smith; P A D'Amore
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy.

Authors:  Maria Enge; Mattias Bjarnegård; Holger Gerhardt; Erika Gustafsson; Mattias Kalén; Noomi Asker; Hans-Peter Hammes; Moshe Shani; Reinhardt Fässler; Christer Betsholtz
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

5.  Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.

Authors:  Shu-Ching Shih; Meihua Ju; Nan Liu; Lois E H Smith
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

6.  Molecular profiling of angiogenesis markers.

Authors:  Shu-Ching Shih; Gregory S Robinson; Carole A Perruzzi; Alfonso Calvo; Kartiki Desai; Jeffery E Green; Iqbal U Ali; Lois E H Smith; Donald R Senger
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

7.  Pericytes and the pathogenesis of diabetic retinopathy.

Authors:  Hans-Peter Hammes; Jihong Lin; Oliver Renner; Moshe Shani; Andrea Lundqvist; Christer Betsholtz; Michael Brownlee; Urban Deutsch
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

8.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

Authors:  M M Shull; I Ormsby; A B Kier; S Pawlowski; R J Diebold; M Yin; R Allen; C Sidman; G Proetzel; D Calvin
Journal:  Nature       Date:  1992-10-22       Impact factor: 49.962

9.  Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system.

Authors:  Y Sato; R Tsuboi; R Lyons; H Moses; D B Rifkin
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

10.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.

Authors:  L E Benjamin; I Hemo; E Keshet
Journal:  Development       Date:  1998-05       Impact factor: 6.868

View more
  33 in total

Review 1.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

2.  Brain pericytes: emerging concepts and functional roles in brain homeostasis.

Authors:  Masahiro Kamouchi; Tetsuro Ago; Takanari Kitazono
Journal:  Cell Mol Neurobiol       Date:  2011-03       Impact factor: 5.046

3.  Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy.

Authors:  Michael H Davies; Andrew J Stempel; Kristin E Hubert; Michael R Powers
Journal:  Dev Dyn       Date:  2010-06       Impact factor: 3.780

4.  Defective retinal vascular endothelial cell development as a consequence of impaired integrin αVβ8-mediated activation of transforming growth factor-β.

Authors:  Thomas D Arnold; Gina M Ferrero; Haiyan Qiu; Isabella T Phan; Rosemary J Akhurst; Eric J Huang; Louis F Reichardt
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

5.  Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.

Authors:  Barbara Sennino; Beverly L Falcón; Dilara McCauley; Tom Le; Thomas McCauley; Jeffrey C Kurz; Amy Haskell; David M Epstein; Donald M McDonald
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

6.  Pericyte Rho GTPase mediates both pericyte contractile phenotype and capillary endothelial growth state.

Authors:  Matthew E Kutcher; Alexey Y Kolyada; Howard K Surks; Ira M Herman
Journal:  Am J Pathol       Date:  2007-06-07       Impact factor: 4.307

7.  Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258.

Authors:  Yuqing Liu; Xiao Ming Wen; Eric Lik Hang Lui; Scott L Friedman; Wei Cui; Nancy Pei Shan Ho; Lei Li; Tao Ye; Sheung Tat Fan; Hui Zhang
Journal:  Lab Invest       Date:  2009-08-10       Impact factor: 5.662

8.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

9.  Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cells.

Authors:  Filip Roudnicky; Jitao David Zhang; Bo Kyoung Kim; Nikhil J Pandya; Yanjun Lan; Lisa Sach-Peltason; Heloise Ragelle; Pamela Strassburger; Sabine Gruener; Mirjana Lazendic; Sabine Uhles; Franco Revelant; Oliv Eidam; Gregor Sturm; Verena Kueppers; Klaus Christensen; Leonard D Goldstein; Manuel Tzouros; Balazs Banfai; Zora Modrusan; Martin Graf; Christoph Patsch; Mark Burcin; Claas A Meyer; Peter D Westenskow; Chad A Cowan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-05       Impact factor: 11.205

10.  Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity.

Authors:  Tailoi Chan-Ling; Matthew Philip Page; Tom Gardiner; Louise Baxter; Emilia Rosinova; Suzanne Hughes
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.